Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

NK cells with tissue-resident traits shape response to immunotherapy by inducing adaptive antitumor immunity
Nicole Kirchhammer, Marcel P. Trefny, Marina Natoli, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 653
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
Karin E. de Visser, Johanna A. Joyce
Cancer Cell (2023) Vol. 41, Iss. 3, pp. 374-403
Open Access | Times Cited: 1539
Immune checkpoint therapy for solid tumours: clinical dilemmas and future trends
Qian Sun, Zhenya Hong, Cong Zhang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 245
Natural killer cell therapies
Éric Vivier, Lucas Rebuffet, Émilie Narni-Mancinelli, et al.
Nature (2024) Vol. 626, Iss. 8000, pp. 727-736
Closed Access | Times Cited: 140
Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
Nicole Kirchhammer, Marcel P. Trefny, Priska Auf der Maur, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 670
Closed Access | Times Cited: 117
Targeting the Siglec–sialic acid axis promotes antitumor immune responses in preclinical models of glioblastoma
Philip Schmassmann, Julien Roux, Alicia Buck, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 705
Closed Access | Times Cited: 45
The role of tumor microenvironment in drug resistance: emerging technologies to unravel breast cancer heterogeneity
Vincenzo Salemme, Giorgia Centonze, Lidia Avalle, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 42
NK cell-triggered CCL5/IFNγ-CXCL9/10 axis underlies the clinical efficacy of neoadjuvant anti-HER2 antibodies in breast cancer
Sara Santana-Hernández, Jesús Suárez-Olmos, Sònia Servitja, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 13
Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation
Abdulla Berjis, Deeksha Muthumani, Oscar A. Aguilar, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Targets of tumor microenvironment for potential drug development
Ling Zhang, Ziruoyu Wang, Kailu Liu, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 11
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung
Eduardo Moreo, Aitor Jarit-Cabanillas, Iñaki Robles‐Vera, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 19
The Role of Chemokines in Orchestrating the Immune Response to Pancreatic Ductal Adenocarcinoma
Alexander Lekan, Louis M. Weiner
Cancers (2024) Vol. 16, Iss. 3, pp. 559-559
Open Access | Times Cited: 6
Cardinal features of immune memory in innate lymphocytes
Endi K. Santosa, Joseph C. Sun
Nature Immunology (2023) Vol. 24, Iss. 11, pp. 1803-1812
Open Access | Times Cited: 14
Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer
Shin Saito, Michihisa Kono, Hoang C.B. Nguyen, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 9, pp. 1934-1944
Open Access | Times Cited: 5
Anti-PD-1 cis-delivery of low-affinity IL-12 activates intratumoral CD8+T cells for systemic antitumor responses
Zhuangzhi Zou, Jiao Shen, Diyuan Xue, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 5
Interleukin-12 Delivery Strategies and Advances in Tumor Immunotherapy
Chunyan Dong, Dejiang Tan, Huimin Sun, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 10, pp. 11548-11579
Open Access | Times Cited: 4
Transcriptional signature of CD56bright NK cells predicts favourable prognosis in bladder cancer
Md. Abdullah‐Al‐Kamran Khan, Alexander James Sedgwick, Yuhan Sun, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Tissue-resident immune cells: from defining characteristics to roles in diseases
Jia Li, Xiao Chu, Chunxiang Li, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access
Metformin as an immunomodulatory agent in enhancing head and neck squamous cell carcinoma therapies
Wenting Li, Naiming Liu, Mingwei Chen, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189262-189262
Closed Access
Current status and future prospects of molecular imaging in targeting the tumor immune microenvironment
Xiang Wang, Wen Shen, Lan Yao, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Multimodal Artificial Intelligence‐Based Virtual Biopsy for Diagnosing Abdominal Lavage Cytology‐Positive Gastric Cancer
Pingan Ding, Jiaxuan Yang, Honghai Guo, et al.
Advanced Science (2025)
Open Access
NLRP4 unlocks an NK/macrophages-centered ecosystem to suppress non-small cell lung cancer
Zhouwenli Meng, Jian Li, Hui Wang, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access
IL-18-primed NK cells recruit dendritic cells and potentiate tumor therapy mediated by PD-1 blockade
Yoshiya Ohno, Haruki Okamura, Hideo Yagita∥, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Single-cell transcriptomics reveals immunosuppressive microenvironment and highlights tumor-promoting macrophage cells in Glioblastoma
Han Cheng, Yan Yan, Biao Zhang, et al.
PLoS ONE (2025) Vol. 20, Iss. 4, pp. e0312764-e0312764
Open Access
Natural killer cells’ functional impairment drives the immune escape of pre-malignant clones in early-stage myelodysplastic syndromes
Juan José Rodríguez‐Sevilla, Irene Gañán‐Gómez, Bijender Kumar, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Beyond Adaptive Immunity: Trained Innate Immune Responses as a Novel Frontier in Hepatocellular Carcinoma Therapy
Ching‐Hua Hsieh, Pei-Chin Chuang, Yueh‐Wei Liu
Cancers (2025) Vol. 17, Iss. 7, pp. 1250-1250
Open Access
Page 1 - Next Page

Scroll to top